The Journal of Urology
Volume 182, Issue 6, Supplement , Pages S51-S56 , December 2009

Diabetes Mellitus and Urinary Tract Infection: Epidemiology, Pathogenesis and Proposed Studies in Animal Models

  • Swaine L. Chen

      Affiliations

    • Department of Molecular Microbiology, Washington University School of Medicine, Saint Louis, Missouri
  • ,
  • Sara L. Jackson

      Affiliations

    • Department of Medicine, University of Washington and Seattle Epidemiologic Research and Information Center, Veterans Affairs Puget Sound Health Care System, Seattle, Washington
  • ,
  • Edward J. Boyko

      Affiliations

    • Department of Medicine, University of Washington and Seattle Epidemiologic Research and Information Center, Veterans Affairs Puget Sound Health Care System, Seattle, Washington
    • Corresponding Author InformationCorrespondence: Department of Medicine, University of Washington, 1100 Olive Way, Suite 1400, Seattle, Washington 98101 (telephone: 206-277-4618; FAX: 206-764-2563)

References 

  1. Boyko EJ, Fihn SD, Scholes D, et al. Risk of urinary tract infection and asymptomatic bacteriuria among diabetic and nondiabetic postmenopausal women. Am J Epidemiol. 2005;161:557
  2. Boyko EJ, Fihn SD, Scholes D, et al. Diabetes and the risk of acute urinary tract infection among postmenopausal women. Diabetes Care. 2002;25:1778
  3. Brown JS, Vittinghoff E, Kanaya AM, et al. Urinary tract infections in postmenopausal women: effect of hormone therapy and risk factors. Obstet Gynecol. 2001;98:1045
  4. Muller LM, Gorter KJ, Hak E, et al. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis. 2005;41:281
  5. Shah BR, Hux JE. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care. 2003;26:510
  6. Valerius NH, Eff C, Hansen NE, et al. Neutrophil and lymphocyte function in patients with diabetes mellitus. Acta Med Scand. 1982;211:463
  7. Hosking DJ, Bennett T, Hampton JR. Diabetic autonomic neuropathy. Diabetes. 1978;27:1043
  8. Geerlings SE, Stolk RP, Camps MJ et al: Asymptomatic bacteriuria may be considered a complication in women with diabetes. Diabetes Mellitus Women Asymptomatic Bacteriuria Utrecht Study Group. Diabetes Care 200; 23: 744.
  9. Geerlings SE, Stolk RP, Camps MJ, et al. Risk factors for symptomatic urinary tract infection in women with diabetes. Diabetes Care. 2000;23:1737
  10. Czaja CA, Rutledge BN, Cleary PA, et al. Urinary tract infections in women with type 1 diabetes mellitus: survey of female participants in the epidemiology of diabetes interventions and complications study cohort. J Urol. 2009;181:1129
  11. Geerlings SE. Urinary tract infections in patients with diabetes mellitus: epidemiology, pathogenesis and treatment. Int J Antimicrob Agents. 2008;31(suppl.):S54
  12. Geerlings SE, Brouwer EC, Gaastra W, et al. Virulence factors of Escherichia coli isolated from urine of diabetic women with asymptomatic bacteriuria. Adv Exp Med Biol. 2000;485:249
  13. Geerlings SE, Meiland R, van Lith EC, et al. Adherence of type 1-fimbriated Escherichia coli to uroepithelial cells: more in diabetic women than in control subjects. Diabetes Care. 2002;25:1405
  14. Meiland R, Geerlings SE, Stolk RP, et al. Asymptomatic bacteriuria in women with diabetes mellitus: effect on renal function after 6 years of follow-up. Arch Intern Med. 2006;166:2222
  15. Geerlings SE, Brouwer EC, Van Kessel KC, et al. Cytokine secretion is impaired in women with diabetes mellitus. Eur J Clin Invest. 2000;30:995
  16. Truzzi JC, Almeida FM, Nunes EC, et al. Residual urinary volume and urinary tract infection—when are they linked?. J Urol. 2008;180:182
  17. Rosen DA, Hung CS, Kline KA, et al. Streptozocin-induced diabetic mouse model of urinary tract infection. Infect Immun. 2008;76:4290
  18. Schilling JD, Martin SM, Hung CS, et al. Toll-like receptor 4 on stromal and hematopoietic cells mediates innate resistance to uropathogenic Escherichia coli. Proc Natl Acad Sci U S A. 2003;100:4203
  19. Anderson GG, Palermo JJ, Schilling JD, et al. Intracellular bacterial biofilm-like pods in urinary tract infections. Science. 2003;301:105
  20. Rosen DA, Pinkner JS, Jones JM, et al. Utilization of an intracellular bacterial community pathway in Klebsiella pneumoniae urinary tract infection and the effects of FimK on type 1 pilus expression. Infect Immun. 2008;76:3337
  21. Martinez JJ, Mulvey MA, Schilling JD, et al. Type 1 pilus-mediated bacterial invasion of bladder epithelial cells. EMBO J. 2000;19:2803
  22. Justice SS, Hung C, Theriot JA, et al. Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. Proc Natl Acad Sci U S A. 2004;101:1333
  23. Mulvey MA, Schilling JD, Hultgren SJ. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect Immun. 2001;69:4572
  24. Mysorekar IU, Hultgren SJ. Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract. Proc Natl Acad Sci U S A. 2006;103:14170
  25. Schilling JD, Lorenz RG, Hultgren SJ. Effect of trimethoprim-sulfamethoxazole on recurrent bacteriuria and bacterial persistence in mice infected with uropathogenic Escherichia coli. Infect Immun. 2002;70:7042
  26. Garofalo CK, Hooton TM, Martin SM, et al. Escherichia coli from urine of female patients with urinary tract infections is competent for intracellular bacterial community formation. Infect Immun. 2007;75:52
  27. Rosen DA, Hooton TM, Stamm WE, et al. Detection of intracellular bacterial communities in human urinary tract infection. PLoS Med. 2007;4:e329
  28. Rasko DA, Rosovitz MJ, Myers GS, et al. The pangenome structure of Escherichia coli: comparative genomic analysis of E. coli commensal and pathogenic isolates. J Bacteriol. 2008;190:6881
  29. Johnson JR, Scheutz F, Ulleryd P, et al. Phylogenetic and pathotypic comparison of concurrent urine and rectal Escherichia coli isolates from men with febrile urinary tract infection. J Clin Microbiol. 2005;43:3895
  30. Lloyd AL, Rasko DA, Mobley HL. Defining genomic islands and uropathogen-specific genes in uropathogenic Escherichia coli. J Bacteriol. 2007;189:3532
  31. Hannan TJ, Mysorekar IU, Chen SL, et al. LeuX tRNA-dependent and -independent mechanisms of Escherichia coli pathogenesis in acute cystitis. Mol Microbiol. 2008;67:116
  32. Xie B, Zhou G, Chan SY, et al. Distinct glycan structures of uroplakins Ia and Ib: structural basis for the selective binding of FimH adhesin to uroplakin Ia. J Biol Chem. 2006;281:14644
  33. Sokurenko EV, Chesnokova V, Dykhuizen DE, et al. Pathogenic adaptation of Escherichia coli by natural variation of the FimH adhesin. Proc Natl Acad Sci U S A. 1998;95:8922
  34. Sokurenko EV, Feldgarden M, Trintchina E, et al. Selection footprint in the FimH adhesin shows pathoadaptive niche differentiation in Escherichia coli. Mol Biol Evol. 2004;21:1373
  35. Ronald LS, Yakovenko O, Yazvenko N, et al. Adaptive mutations in the signal peptide of the type 1 fimbrial adhesin of uropathogenic Escherichia coli. Proc Natl Acad Sci U S A. 2008;105:10937
  36. Chen SL, Hung CS, Pinkner JS et al: Positive selection identifies an in vivo role for FimH during urinary tract infection in addition to mannose binding. Unpublished data.
  37. Wright KJ, Seed PC, Hultgren SJ. Development of intracellular bacterial communities of uropathogenic Escherichia coli depends on type 1 pili. Cell Microbiol. 2007;9:2230
  38. Bishop BL, Duncan MJ, Song J, et al. Cyclic AMP-regulated exocytosis of Escherichia coli from infected bladder epithelial cells. Nat Med. 2007;13:625
  39. Thumbikat P, Berry RE, Zhou G, et al. Bacteria-induced uroplakin signaling mediates bladder response to infection. PLoS Pathog. 2009;5:e1000415
  40. Connell I, Agace W, Klemm P, et al. Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract. Proc Natl Acad Sci U S A. 1996;93:9827
  41. Lane MC, Lockatell V, Monterosso G, et al. Role of motility in the colonization of uropathogenic Escherichia coli in the urinary tract. Infect Immun. 2005;73:7644
  42. Wright KJ, Seed PC, Hultgren SJ. Uropathogenic Escherichia coli flagella aid in efficient urinary tract colonization. Infect Immun. 2005;73:7657
  43. Justice SS, Hunstad DA, Seed PC, et al. Filamentation by Escherichia coli subverts innate defenses during urinary tract infection. Proc Natl Acad Sci U S A. 2006;103:19884
  44. Justice SS, Lauer SR, Hultgren SJ, et al. Maturation of intracellular Escherichia coli communities requires SurA. Infect Immun. 2006;74:4793
  45. Hagan EC, Mobley HL. Haem acquisition is facilitated by a novel receptor Hma and required by uropathogenic Escherichia coli for kidney infection. Mol Microbiol. 2009;71:79
  46. Smith YC, Rasmussen SB, Grande KK, et al. Hemolysin of uropathogenic Escherichia coli evokes extensive shedding of the uroepithelium and hemorrhage in bladder tissue within the first 24 hours after intraurethral inoculation of mice. Infect Immun. 2008;76:2978
  47. Rippere-Lampe KE, O'Brien AD, Conran R, et al. Mutation of the gene encoding cytotoxic necrotizing factor type 1 (cnf(1)) attenuates the virulence of uropathogenic Escherichia coli. Infect Immun. 2001;69:3954
  48. Johnson DE, Drachenberg C, Lockatell CV, et al. The role of cytotoxic necrotizing factor-1 in colonization and tissue injury in a murine model of urinary tract infection. FEMS Immun Med Microbiol. 2000;28:37
  49. Lane MC, Mobley HL. Role of P-fimbrial-mediated adherence in pyelonephritis and persistence of uropathogenic Escherichia coli (UPEC) in the mammalian kidney. Kidney Int. 2007;72:19
  50. Lloyd AL, Henderson TA, Vigil PD, et al. Genomic islands of uropathogenic Escherichia coli contribute to virulence. J Bacteriol. 2009;191:3469

 Supported by National Institutes of Health Grants DK081620 (SLC), DK64540 (SLC), DK51406 (SLC), DK43134 (EJB) and P30-DK17047 (EJB) through the Diabetes Endocrinology Research Center at University of Washington, Seattle, Washington.

PII: S0022-5347(09)01952-1

doi: 10.1016/j.juro.2009.07.090

The Journal of Urology
Volume 182, Issue 6, Supplement , Pages S51-S56 , December 2009